A Trial to Evaluate Efficacy and Safety of the Combination Therapy of Genexol®-PM Plus Carboplatin® Compared to Genexol® Plus Carboplatin® as a Firstline Treatment in Subjects With Ovarian Cancer (GPMOC202)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01276548
Recruitment Status : Completed
First Posted : January 13, 2011
Last Update Posted : May 9, 2017
Information provided by (Responsible Party):
Samyang Biopharmaceuticals Corporation

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : May 2012
  Study Completion Date : September 2012